Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggrenox Tolerability in Taiwanese Stroke/TIA Patients
NCT00274586Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2002
- Primary completion
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dipyridamole in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by Boehringer Ingelheim. Started Sep 2002; status: completed.
02
Drugs
dipyridamole
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT00274586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274586.